Loading the security overview…
Where the tokens are
Trade CL perps| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q2 FY26ended Jun 30, 2026 | Aug 7, 2026 | $0.86 | −5.5% | $5.36B | +4.9% | $0.96 |
| Q1 FY26ended Mar 31, 2026 | May 1, 2026 | $0.80 | −5.9% | $5.32B | +8.4% | $0.95 |
| Q4 FY25ended Dec 31, 2025 | — | −$0.05 | −105.6% | $5.23B | +5.8% | — |
| Q3 FY25ended Sep 30, 2025 | — | $0.91 | +1.1% | $5.13B | +1.9% | — |
| Q2 FY25ended Jun 30, 2025 | — | $0.91 | +2.2% | $5.11B | +1.0% | — |
| Q1 FY25ended Mar 31, 2025 | — | $0.85 | +2.4% | $4.91B | −3.0% | — |
| Q4 FY24ended Dec 31, 2024 | — | $0.90 | +3.4% | $4.95B | −0.1% | — |
| Q3 FY24ended Sep 30, 2024 | — | $0.90 | +4.7% | $5.03B | +2.4% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Colgate-Palmolive shares, not any token. As of Aug 7, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q2 FY24ended Jun 30, 2024 | — | $0.89 | — | $5.06B | — | — |
| Q1 FY24ended Mar 31, 2024 | — | $0.83 | — | $5.07B | — | — |
| Q4 FY23ended Dec 31, 2023 | — | $0.87 | — | $4.95B | — | — |
| Q3 FY23ended Sep 30, 2023 | — | $0.86 | — | $4.92B | — | — |